Publications by authors named "John More"

Claim this Profile
M
Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial.
Vatsala Rajendram, Martyn Paddick, John More

PLoS One· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective antibody concentrations in primary immunodeficiency following infusion with 5% or 10% intravenous immunoglobulin.
Martyn Paddick, Kim Clark, Eric Wolford, John More

Allergy Asthma Proc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional effects of haemoglobin can be rescued by haptoglobin in an in vitro model of subarachnoid haemorrhage.
Hannah Warming, Katrin Deinhardt, Patrick Garland, John More, Diederik Bulters

J Neurochem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage.
Patrick Garland, Matt Morton, Ardalan Zolnourian, Andrew Durnford, Ben Gaastra, John More

Brain· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years' experience of the plasma protein manufacturers.
Nathan J Roth, Herbert O Dichtelmüller, Fabrizio Fabbrizzi, Eckhard Flechsig, Albrecht Gröner, Elisa Moretti, John More

Transfusion· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemoglobin causes neuronal damage which is preventable by haptoglobin.
Patrick Garland, Matthew J Morton, William Haskins, Ardalan Zolnourian, Andrew Durnford, John More

Brain Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an intravenous immunoglobulin with improved safety and functional activity.
Peter L Roberts, Tara Dolan, Martyn Paddick, Shirley Stagg, John E More

Biologicals· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.
Mark B Pepys, J Ruth Gallimore, Joanne Lloyd, Zhanhong Li, David Graham, John More

J Immunol Methods· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus inactivation in albumin by a combination of alkali conditions and high temperature.
Peter L Roberts, John More, Jackie Rott, David Lewin

Biologicals· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis